Latest Global X News

Global X Rare Earth and Critical Metals ETF delivered a sharp lift in audited profit for the year ended 30 June 2026, while net assets more than tripled as investors added capital. The result was driven mainly by realised gains on listed critical-metals equities, alongside a distribution of 112.44 cents per unit.

Global X S&P World ex Australia GARP ETF reported audited profit of AUD 9.791 million for the year ended 30 June 2026, more than triple the prior-year result. Net assets rose to AUD 140.276 million as market gains combined with substantial investor applications.

Global X EURO STOXX 50 ETF delivered a higher annual profit and a sharp increase in net assets as investor applications accelerated. The audited report also highlights the fund’s sizeable exposure to European equities and euro-Australian dollar movements.

Global X Defence Tech ETF reported a $13.84 million loss for the year ended 30 June 2026, reversing a $7.50 million profit a year earlier. The result was driven by $14.48 million in net losses on investments and foreign exchange, even as investor applications lifted net assets to $112.56 million.

Global X Australian Bank Credit ETF more than doubled its net assets to $184 million in the year to 30 June 2026, while profit rose to $6.9 million. The audited report also shows a larger exposure to BBB-rated debt and a sharp increase in distributions payable.

Global X FANG+ ETF reported a sharp decline in annual profit, while its net asset value fell by more than 10% after 30 June as underlying technology stocks weakened. The audited fund still grew net assets to AUD1.606 billion and declared a 235.84 cents-per-unit distribution.

Global X China Tech ETF reported an AUD15.727 million profit for the year ended 30 June 2026, powered by gains in listed Chinese technology investments. But the fund disclosed that its net asset value has since fallen by more than 10%, leaving the audited result looking increasingly historical.

Global X S&P Biotech ETF (ASX:CURE) reported a AUD22.601 million profit for the year to 30 June 2026, reversing the prior year’s AUD2.863 million loss. The turnaround was driven overwhelmingly by gains in listed biotech securities and foreign exchange, rather than recurring income.

Global X S&P/ASX 200 Covered Call Complex ETF reported a sharp lift in annual profit as realised investment gains strengthened, while net assets passed $100 million. The fund declared 23.80 cents per unit for its June distribution, but its returns remain exposed to equity prices, options and a suspended holding valued at zero.

Global X Artificial Intelligence Infrastructure ETF (ASX:AINF) reported a $25.291 million profit for its first full financial year, driven overwhelmingly by investment gains. Net assets climbed to $169.603 million after almost $147.2 million of new unit applications, while the fund paid a 61.64 cents per unit distribution.

Global X Battery Tech & Lithium ETF delivered a sharply higher profit for the year ended 30 June 2026, driven by large fair-value gains across its listed equity portfolio. But the fund says its net asset value has since fallen by more than 10% as underlying battery and lithium investments weakened.

Global X Metal Securities Australia Limited has issued a prospectus for five classes of securities tracking gold, silver, platinum, palladium, and a precious metals basket. The securities are physically backed, traded on ASX under AQUA Rules, and managed by JPMorgan Chase Bank.